GL1X · GenesisL1 explorer

MolNFT v1 · #4104 · protein

Imp-1 metallo beta-lactamase from pseudomonas aeruginosa in complex with a mercaptocarboxylate inhibitor

1DD6: “Imp-1 metallo beta-lactamase from pseudomonas aeruginosa in complex with a mercaptocarboxylate inhibitor”. X-ray diffraction, 3 ligands (MCI, ZN, SO4), 3 pockets (best druggability 0.52). MolNFT v1 #4104 on GenesisL1: 3D structure…

PDB
1DD6
Type
protein
Length
433 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Imp-1 metallo beta-lactamase
EC
3.5.2.6
UniProt
P52699
Ligands
MCI, ZN, SO4
Pockets
3 · best druggability 0.52

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AImp-1 metallo beta-lactamase (EC 3.5.2.6)protein21627% helix, 32% strandP52699
BImp-1 metallo beta-lactamase (EC 3.5.2.6)protein21726% helix, 32% strandP52699

Ligands and binding sites

  • MCI · (2-mercaptomethyl-4-phenyl-butyrylimino)-(5-tetrazol-1-ylmethyl-thiophen-2-yl)-acetic acid · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12200.520.7728ZN, MCI
21930.500.7631ZN, MCI
3620.380.7914empty

Compared structures

  • 1DD6 · Imp-1 metallo beta-lactamase from pseudomonas aeruginosa in complex with a… · the same entry in another collection · chain A against A, TM-score 1.00
  • P52699 · AlphaFold monomer V2.0 prediction for metallo-beta-lactamase type 2 (P52699) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.